Aytu Biopharma Inc expected to post a loss of 25 cents a share - Earnings Preview

Aytu Biopharma

09/02/2024 21:40

* Aytu Biopharma Inc  AYTU.OQ   AYTU.O  is expected to show
a fall
in quarterly revenue when it reports  results on May 9
(estimated) for the period ending December 31 2023
    * The Denver Colorado-based  company is expected to report a
17.3% decrease in revenue to $21.745 million from $26.28 million
a year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Aytu Biopharma Inc is
for a
loss of 25 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aytu
Biopharma
Inc is $5.00​, above​ its last closing price of $2.65. ​​​

This summary was machine generated February 9 at 21:40 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)